This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.


Explore the range of services and free support we offer the life sciences industry. We can support at any step of the development pipeline, from helping to develop initial designs, to set-up and delivery of studies.

Contact us to find out how we can support you.

Run a commercial study in the NHS

From identifying ideal NHS sites to performance monitoring, we provide a range of support to help the life sciences industry run studies in the NHS. You can also find out about our new national Patient Recruitment Centres.

NIHR Services for MedTech

We work in partnership with medical device, digital technology and diagnostic companies (collectively known as MedTech) to help them successfully translate innovative ideas into the clinical setting.


Access our expertise

Discover how we can help you identify, partner and work with the UK’s leading academics and clinical experts and access NHS research intelligence. For example, why not learn more about our Patient Engagement in Clinical Development Service?


Other key information about what NIHR can offer to industry includes:

Apply for funding
There are a number of NIHR funding programmes which industry can apply for in order to support their health and care research

Collaborate with us
We offer a range of opportunities for industry to partner with our experts; from Translational Research Collaborations, to jointly funding researcher career development.

Access NIHR facilities and services
Support for the life sciences industry and other partners to access data, samples and analytical services

Or, find out more about:

Our response to COVID-19

At the beginning of the pandemic, we streamlined the COVID-19 research set-up process in the UK by establishing a single, collective UK system-wide approach involving NIHR, Public Health England, UK Research & Innovation (UKRI), the Health Research Authority (HRA), Medicines and Healthcare products Regulatory Agency (MHRA) and others.

Due to the drop in COVID-19 case numbers and significant progress with the vaccine roll-out, we are no longer accepting applications for studies to be designated as Urgent Public Health (UPH). However existing UPH studies will continue to be prioritised over the coming weeks, and new COVID-19 portfolio studies will be supported in line with local priorities and capacity. Find out more about NIHR support for COVID-19 research

You can read examples of how our support has helped, such as:

You may also find the following resources useful:

Managing research recovery 

With the pressures of the pandemic beginning to ease and COVID-19 caseloads falling, work is underway to support the recovery of research into other conditions, and to increase the strength of the UK’s research base and life sciences sector. This supports the vision set out by the Department of Health and Social Care in the document Saving and Improving Lives: the future of UK clinical research delivery.

Find out how we are managing recovery and work to support non-COVID 19 studies to improve research recovery, resilience and growth. 

Latest news about the Life Sciences Industry

You can stay up to date by signing up for the NIHR life sciences industry newsletter

Latest Case Studies about the Life Sciences Industry